{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:25:36Z","timestamp":1769603136906,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"am","delay-in-days":397,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK089507"],"award-info":[{"award-number":["P30DK089507"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1T32NR019035"],"award-info":[{"award-number":["1T32NR019035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GILL21H0"],"award-info":[{"award-number":["GILL21H0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SAGEL07B0"],"award-info":[{"award-number":["SAGEL07B0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","cysticfibrosisjournal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jcf.2024.05.014","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T04:28:36Z","timestamp":1718166516000},"page":"1106-1111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Symptom phenotyping in people with cystic fibrosis during acute pulmonary exacerbations using machine-learning K-means clustering analysis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5183-9338","authenticated-orcid":false,"given":"Eliana R.","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Dill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6172-4465","authenticated-orcid":false,"given":"Scott D.","family":"Sagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9348-8740","authenticated-orcid":false,"given":"Michelle L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0379-4761","authenticated-orcid":false,"given":"Sharon D.","family":"Horner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-8148","authenticated-orcid":false,"given":"Julie A.","family":"Zu\u00f1iga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcf.2024.05.014_bib0001","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-0636","article-title":"Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry","volume":"161","author":"MacKenzie","year":"2014","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.jcf.2024.05.014_bib0002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.jcf.2024.05.014_bib0003","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1164\/rccm.200407-900OC","article-title":"Use of lung transplantation survival models to refine patient selection in cystic fibrosis","volume":"171","author":"Liou","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2024.05.014_bib0004","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1742395318772647","article-title":"Adult patients' experiences of symptom management during pulmonary exacerbations in cystic fibrosis: a thematic synthesis of qualitative research","volume":"15","author":"Schmid-Mohler","year":"2019","journal-title":"Chronic Illn"},{"issue":"19","key":"10.1016\/j.jcf.2024.05.014_bib0005","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jcf.2024.05.014_bib0006","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ppul.22652","article-title":"Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis","volume":"48","author":"Wagener","year":"2013","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"10.1016\/j.jcf.2024.05.014_bib0007","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1513\/AnnalsATS.202111-1266OC","article-title":"Acute pulmonary exacerbation phenotypes in patients with cystic fibrosis","volume":"19","author":"Carter","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.jcf.2024.05.014_bib0008","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2024.05.014_bib0009","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcf.2024.05.014_bib0010","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1188\/06.ONF.E79-E89","article-title":"Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis","volume":"33","author":"Miaskowski","year":"2006","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"10.1016\/j.jcf.2024.05.014_bib0011","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ahj.2010.01.003","article-title":"Differences in mortality in acute coronary syndrome symptom clusters","volume":"159","author":"Riegel","year":"2010","journal-title":"Am Heart J"},{"issue":"17\u201318","key":"10.1016\/j.jcf.2024.05.014_bib0012","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1111\/jocn.12526","article-title":"Symptom cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary disease","volume":"23","author":"Park","year":"2014","journal-title":"J Clin Nurs"},{"issue":"5","key":"10.1016\/j.jcf.2024.05.014_bib0013","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1513\/AnnalsATS.201410-493OC","article-title":"Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation","volume":"12","author":"Sagel","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"10.1016\/j.jcf.2024.05.014_bib0014","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2024.05.014_bib0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2024.05.014_bib0016","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ppul.1950150204","article-title":"Pulmonary function between 6 and 18 years of age","volume":"15","author":"Wang","year":"1993","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.jcf.2024.05.014_bib0017","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcf.2009.04.003","article-title":"Patient-reported respiratory symptoms in cystic fibrosis","volume":"8","author":"Goss","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2024.05.014_bib0018","first-page":"1","article-title":"Nbclust: an R package for determining the relevant number of clusters in a data set","volume":"61","author":"Charrad","year":"2019","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jcf.2024.05.014_bib0019","series-title":"Euclidean Cluster Analysis","author":"Beale","year":"1969"},{"key":"10.1016\/j.jcf.2024.05.014_bib0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02294245","article-title":"An examination of procedures for determining the number of clusters in a data set","volume":"50","author":"Milligan","year":"1985","journal-title":"Psychometrika"},{"issue":"1","key":"10.1016\/j.jcf.2024.05.014_bib0021","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/ci00065a010","article-title":"New index for clustering tendency and its application to chemical problems","volume":"30","author":"Lawson","year":"1990","journal-title":"J Chem Inf Comput Sci"},{"key":"10.1016\/j.jcf.2024.05.014_bib0022","first-page":"84","article-title":"Package \u2018factoextra\u2019: extract and visualize the results of multivariate data analyses","author":"Kassambara","year":"2020","journal-title":"CRAN- R Package"},{"issue":"5","key":"10.1016\/j.jcf.2024.05.014_bib0023","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"Sanders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2024.05.014_bib0024","first-page":"12","article-title":"Comparison between cluster techniques for clinical data","volume":"7","author":"Elsayed","year":"2019","journal-title":"Int J Math Stat Invent"},{"issue":"6","key":"10.1016\/j.jcf.2024.05.014_bib0025","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jcf.2019.05.009","article-title":"Correspondence between lung function and symptom measures from the Cystic Fibrosis Respiratory Symptom Diary-Chronic Respiratory Infection Symptom Score (CFRSD-CRISS)","volume":"18","author":"Gold","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2024.05.014_bib0026","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcf.2020.08.006","article-title":"Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment","volume":"20","author":"VanDevanter","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2024.05.014_bib0027","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcf.2021.12.003","article-title":"C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response","volume":"21","author":"VanDevanter","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2024.05.014_bib0028","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jcf.2021.02.014","article-title":"Health care costs related to home spirometry in the eICE randomized trial","volume":"21","author":"Franz","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.jcf.2024.05.014_bib0029","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/MLR.0b013e31822efb09","article-title":"How dangerous is a day in hospital? A model of adverse events and length of stay for medical inpatients","volume":"49","author":"Hauck","year":"2011","journal-title":"Med Care"},{"issue":"2","key":"10.1016\/j.jcf.2024.05.014_bib0030","first-page":"281","article-title":"CFTR modulators: transformative therapies for cystic fibrosis","volume":"27","author":"Dwight","year":"2021","journal-title":"J Manag Care Spec Pharm"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T19:26:46Z","timestamp":1733254006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324000778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1569199324000778"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.05.014","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptom phenotyping in people with cystic fibrosis during acute pulmonary exacerbations using machine-learning K-means clustering analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}